Literature DB >> 8195332

Manifestations of diabetes mellitus on mouse preimplantation development: effect of elevated concentration of metabolic intermediates.

K H Moley1, W K Vaughn, M P Diamond.   

Abstract

The metabolic derangements of pregnancies complicated by diabetes mellitus, specifically hyperglycaemia and hyperketonaemia, are known to be teratogenic during the period of organogenesis in animals. We have shown previously that poorly controlled diabetes mellitus impairs in-vivo and in-vitro mouse preimplantation embryo growth, and that culturing embryos in elevated glucose concentrations only partially recreates this developmental delay. To extend this observation we examined the effect on mouse preimplantation embryo growth of elevated concentrations of other metabolic intermediates, which may be deranged in diabetes mellitus, namely lipids, lactate, glycerol, amino acids, and ketones. Two-cell embryos from ovulation-induced B6C3F1 mice were cultured for 72 h in the presence of added lipids (250 mg/dl), lactate (5 mM), glycerol (160 microM) or mixed amino acids (8.5% travasol, 7 mM) and showed no significant difference in growth over 72 h versus their control groups. However, growth of preimplantation embryos in acetoacetate (10 mM) or in the racemic mixture of DL-beta-hydroxybutyrate (16 and 32 mM) revealed marked retardation versus controls when assessed either by distribution of developmental stages over time (24, 48, 72 h, P < 0.001) or by the difference in the average rank of sums indicating a delay in maturation (P < 0.0001). We conclude that elevated ketone concentrations adversely affect preimplantation embryo development. These findings extend previous studies which correlate uncontrolled diabetes mellitus as well as hyperglycaemia with abnormal organogenesis, and demonstrate that exposure to metabolic derangements may also hinder reproductive performance at even earlier stages in gestation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195332     DOI: 10.1093/oxfordjournals.humrep.a138298

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate.

Authors:  Kieran Clarke; Kirill Tchabanenko; Robert Pawlosky; Emma Carter; Nicholas S Knight; Andrew J Murray; Lowri E Cochlin; M Todd King; Andrea W Wong; Ashley Roberts; Jeremy Robertson; Richard L Veech
Journal:  Regul Toxicol Pharmacol       Date:  2012-04-11       Impact factor: 3.271

2.  In vitro fertilization and embryo transfer in uncontrolled diabetes mellitus.

Authors:  Y Hovav; M Almagor; I Kafka; G Elgavish; H Yaffe
Journal:  J Assist Reprod Genet       Date:  1995-07       Impact factor: 3.412

Review 3.  Maternal diabetes and oocyte quality.

Authors:  Qiang Wang; Kelle H Moley
Journal:  Mitochondrion       Date:  2010-03-11       Impact factor: 4.160

Review 4.  Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes.

Authors:  Ling Gu; Honglin Liu; Xi Gu; Christina Boots; Kelle H Moley; Qiang Wang
Journal:  Cell Mol Life Sci       Date:  2014-10-04       Impact factor: 9.261

5.  Metabolic Profiling in Blastocoel Fluid and Blood Plasma of Diabetic Rabbits.

Authors:  Maria Schindler; Sophia Mareike Pendzialek; Katarzyna Grybel; Tom Seeling; Anne Navarrete Santos
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

6.  β-hydroxybutyrate reduces blastocyst viability via trophectoderm-mediated metabolic aberrations in mice.

Authors:  Emma G Whatley; Thi T Truong; Dagmar Wilhelm; Alexandra J Harvey; David K Gardner
Journal:  Hum Reprod       Date:  2022-08-25       Impact factor: 6.353

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.